Cytokinetics Market Sentiment

Cytokinetics Inc

CYTKNASDAQ

Trade with Public

$63.43

1.812.94%

마지막 업데이트: Oct 14, 4:00 PM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Cytokinetics Market Sentiment - Benzinga

Cytokinetics Market Sentiment

Market sentiment signals for Cytokinetics (CYTK): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 21.2% short float

Options Flow▲ 0.06 P/C ratio

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

25 analysts

Options Flow (P/C)

0.06

More calls — Bullish

866 calls · 52 puts

Avg Consensus PT

$99

+56.3%

Highest Price Target

$140

+120.7%

HC Wainwright & Co.

Lowest Price Target

$56

-11.7%

B of A Securities

Short Interest

21.2%

Rising — Bearish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 8, 2026	RBC Capital	Leonid Timashev—	+78.1%	$112 → $113	Maintained	Outperform
Aug 31, 2026	HC Wainwright & Co.	Joseph Pantginis—	+120.7%	$140 → $140	Maintained	Buy
Aug 13, 2026	Barclays	Emily Field—	+73.4%	$95 → $110	Maintained	Overweight
Aug 13, 2026	JP Morgan	Tessa Romero—	+62.4%	$97 → $103	Maintained	Overweight
Aug 10, 2026	Truist Securities	Srikripa Devarakonda—	+76.5%	$106 → $112	Maintained	Buy
Aug 7, 2026	RBC Capital	Leonid Timashev—	+76.5%	$117 → $112	Maintained	Outperform
Aug 7, 2026	Citizens	Jason N. Butler—	+73.4%	$105 → $110	Maintained	Market Outperform
Aug 7, 2026	Needham	Serge Belanger—	+76.5%	$102 → $112	Maintained	Buy
Jul 7, 2026	RBC Capital	Leonid Timashev—	+84.4%	$119 → $117	Maintained	Outperform
Jun 29, 2026	UBS	Ashwani Verma—	+81.3%	$69 → $115	Upgrade	Neutral→Buy
Jun 24, 2026	Mizuho	Salim Syed—	+86.0%	$100 → $118	Maintained	Outperform
Jun 17, 2026	Needham	Serge Belanger—	+60.8%	$102 → $102	Maintained	Buy
May 19, 2026	Citigroup	Eric Joseph—	+56.1%	$99	Initiate	Buy
May 12, 2026	JP Morgan	Tessa Romero—	+52.9%	$92 → $97	Maintained	Overweight
May 11, 2026	HC Wainwright & Co.	Joseph Pantginis—	+120.7%	$136 → $140	Maintained	Buy
May 7, 2026	Wells Fargo	Yanan Zhu—	+65.5%	$95 → $105	Maintained	Overweight
May 6, 2026	Stifel	James Condulis—	+70.2%	$98 → $108	Maintained	Buy
May 6, 2026	Morgan Stanley	Jeffrey Hung—	+62.4%	$90 → $103	Maintained	Overweight
May 6, 2026	RBC Capital	Leonid Timashev—	+87.6%	$101 → $119	Maintained	Outperform
May 5, 2026	Needham	Serge Belanger—	+60.8%	$85 → $102	Maintained	Buy
Apr 10, 2026	Wells Fargo	Yanan Zhu—	+49.7%	$95	Initiate	Overweight
Apr 6, 2026	Barclays	Gena Wang—	+49.7%	$87 → $95	Maintained	Overweight
Mar 18, 2026	Mizuho	Salim Syed—	+57.6%	$84 → $100	Maintained	Outperform
Mar 17, 2026	JP Morgan	Tessa Romero—	+18.2%	$74 → $75	Maintained	Overweight
Mar 6, 2026	UBS	Ashwani Verma—	+8.8%	$61 → $69	Maintained	Neutral